4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-005593
CVP,Strategy/Corp Development sold 5,635 shares at $88.63 ($499,402)
- CVP,Strategy/Corp Development gave up 4,367 shares (to pay taxes)
- CVP,Strategy/Corp Development acquired 4,767 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-05 | Sale : show line 1 in the form | −5,635 | $88.63 | $499,402 | 56,224.69 | D |
| 2023-05-07 | Exercise or conversion : show line 2 in the form | +4,767 | 60,991.69 | D | ||
| 2023-05-07 | Shares withheld for taxes : show line 3 in the form | −2,968 | $88.74 | $263,380 | 58,023.69 | D |
| 2023-05-08 | Shares withheld for taxes : show line 4 in the form | −1,399 | $88.74 | $124,147 | 56,624.69 | D |
| Open-market sales · 5,635 sh · avg $88.63 · $499,402 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-07 | Exercise or conversion : show line 5 in the form Performance Rights | −4,767 | 2027-05-06 | 4,767 | 1,308 | D |
Loading xslF345X04/doc4.xml…